180 related articles for article (PubMed ID: 15777217)
1. Monoclonal antibody-based targeted therapy in breast cancer.
Altundag K; Esteva FJ; Arun B
Curr Med Chem Anticancer Agents; 2005 Mar; 5(2):99-106. PubMed ID: 15777217
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody-based targeted therapy in breast cancer: current status and future directions.
Bernard-Marty C; Lebrun F; Awada A; Piccart MJ
Drugs; 2006; 66(12):1577-91. PubMed ID: 16956305
[TBL] [Abstract][Full Text] [Related]
3. [Monoclonal antibodies and breast cancer. Current therapeutic progress].
Collignon J; Gennigens C; Rorive A; Coucke P; Lifrange E; Maweja S; Fillet G; Jerusalem G
Rev Med Liege; 2009; 64(5-6):279-83. PubMed ID: 19642459
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant treatment of breast cancer: impact of monoclonal antibody therapy directed against the HER2 receptor.
Simonds HM; Miles D
Expert Opin Biol Ther; 2007 Apr; 7(4):487-91. PubMed ID: 17373900
[TBL] [Abstract][Full Text] [Related]
5. [Human recombinant anti-HER2 monoclonal antibody--a new targeted treatment in breast cancer].
Dank M
Orv Hetil; 2001 Nov; 142(46):2563-8. PubMed ID: 11770175
[TBL] [Abstract][Full Text] [Related]
6. Beyond trastuzumab: overcoming resistance to targeted HER-2 therapy in breast cancer.
Bedard PL; de Azambuja E; Cardoso F
Curr Cancer Drug Targets; 2009 Mar; 9(2):148-62. PubMed ID: 19275756
[TBL] [Abstract][Full Text] [Related]
7. Her2-positive breast cancer: herceptin and beyond.
Dean-Colomb W; Esteva FJ
Eur J Cancer; 2008 Dec; 44(18):2806-12. PubMed ID: 19022660
[TBL] [Abstract][Full Text] [Related]
8. Trastuzumab and breast cancer: developments and current status.
Tokunaga E; Oki E; Nishida K; Koga T; Egashira A; Morita M; Kakeji Y; Maehara Y
Int J Clin Oncol; 2006 Jun; 11(3):199-208. PubMed ID: 16850126
[TBL] [Abstract][Full Text] [Related]
9. Growth factor receptors in breast cancer: potential for therapeutic intervention.
Nahta R; Hortobágyi GN; Esteva FJ
Oncologist; 2003; 8(1):5-17. PubMed ID: 12604728
[TBL] [Abstract][Full Text] [Related]
10. Overview of treatment results with trastuzumab (Herceptin) in metastatic breast cancer.
Hortobagyi GN
Semin Oncol; 2001 Dec; 28(6 Suppl 18):43-7. PubMed ID: 11774205
[TBL] [Abstract][Full Text] [Related]
11. Trastuzumab: a review of its use in the management of HER2-positive metastatic and early-stage breast cancer.
Plosker GL; Keam SJ
Drugs; 2006; 66(4):449-75. PubMed ID: 16597163
[TBL] [Abstract][Full Text] [Related]
12. Progression and treatment of HER2-positive breast cancer.
Davoli A; Hocevar BA; Brown TL
Cancer Chemother Pharmacol; 2010 Mar; 65(4):611-23. PubMed ID: 20087739
[TBL] [Abstract][Full Text] [Related]
13. Ongoing adjuvant trials with trastuzumab in breast cancer.
Tan AR; Swain SM
Semin Oncol; 2003 Oct; 30(5 Suppl 16):54-64. PubMed ID: 14613027
[TBL] [Abstract][Full Text] [Related]
14. The role of trastuzumab in early stage breast cancer: current data and treatment recommendations.
Lin A; Rugo HS
Curr Treat Options Oncol; 2007 Feb; 8(1):47-60. PubMed ID: 17660958
[TBL] [Abstract][Full Text] [Related]
15. Combined biological therapy of breast cancer using monoclonal antibodies directed against HER2/neu protein and vascular endothelial growth factor.
Pegram MD; Reese DM
Semin Oncol; 2002 Jun; 29(3 Suppl 11):29-37. PubMed ID: 12138395
[TBL] [Abstract][Full Text] [Related]
16. Spotlight on Trastuzumab in the management of HER2-positive metastatic and early-stage breast cancer.
Plosker GL; Keam SJ
BioDrugs; 2006; 20(4):259-62. PubMed ID: 16831025
[TBL] [Abstract][Full Text] [Related]
17. Molecular predictors of efficacy to anti-EGFR agents in colorectal cancer patients.
Ruzzo A; Graziano F; Canestrari E; Magnani M
Curr Cancer Drug Targets; 2010 Feb; 10(1):68-79. PubMed ID: 20088793
[TBL] [Abstract][Full Text] [Related]
18. Development and Characterization of a Humanized Anti-HER2 Antibody HuA21 with Potent Anti-Tumor Properties in Breast Cancer Cells.
Li R; Hu S; Chang Y; Zhang Z; Zha Z; Huang H; Shen G; Liu J; Song L; Wei W
Int J Mol Sci; 2016 Apr; 17(4):563. PubMed ID: 27092488
[TBL] [Abstract][Full Text] [Related]
19. Predicting the efficacy of trastuzumab-based therapy in breast cancer: current standards and future strategies.
Singer CF; Köstler WJ; Hudelist G
Biochim Biophys Acta; 2008 Dec; 1786(2):105-13. PubMed ID: 18375208
[TBL] [Abstract][Full Text] [Related]
20. Trastuzumab in breast cancer.
Emens LA; Davidson NE
Oncology (Williston Park); 2004 Aug; 18(9):1117-28; discussion 1131-2, 1137-8. PubMed ID: 15471197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
